Brief: Theravance Biopharma Announces Sale of VIBATIV To Cumberland Pharmaceuticals
06/11/2018 13:44
Nov 6 (Reuters) - Theravance Biopharma Inc CPIX.O :
* THERAVANCE BIOPHARMA INC - SALE OF VIBATIV (TELAVANCIN) TO
CUMBERLAND PHARMACEUTICALS
Source text for Eikon: ID:nPn1X41gsa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM